In Brief
Espuny-Camacho, Arranz et al. show in this article a novel chimeric model of Alzheimer's disease generated using human neurons derived from pluripotent stem cells. This new chimeric model shows degeneration and major loss of human neurons without the presence of Tau tangles.
INTRODUCTION
Alois Alzheimer described in 1906 the main pathological hallmarks of Alzheimer's disease (AD): amyloid-b (Ab) plaques, neurofibrillary pathology and tangles, astrogliosis, and neuronal loss (Alzheimer, 1906) . Cerebrovascular amyloid angiopathy, microgliosis, inflammation, and major synaptic alteration are other pathological features of AD (Katzman, 1986; McGeer et al., 1988; Crews and Masliah, 2010; Spillantini and Goedert, 2013) .
The amyloid hypothesis links abnormally folded Ab peptides in a linear and causal cascade to the other disease hallmarks, including neuronal tangle formation and neuronal cell death (Hardy and Selkoe, 2002; critique in De Strooper and Karran, 2016) . This hypothesis has provided the theoretical basis for the generation of numerous animal models, diagnostics, and therapeutics for AD. However, evolving insights have made increasingly clear that a more complex theory and more elaborate in vivo models are needed to understand the long prodromal phase of the disease (De Strooper and Karran, 2016) . Rodent AD models (Ashe and Zahs, 2010; LaFerla and Green, 2012) usually overexpress mutated forms of the familial AD (FAD)-causing genes APP and/ or PSEN, leading to extensive amyloid plaque deposition, Ab-associated neuroinflammation, and some synaptic dysfunction. However, crucial aspects of the disease process, like neuronal tangle formation and severe neuronal loss, have never been convincingly demonstrated in rodents (Kokjohn and Roher, 2009; Morrissette et al., 2009; Crews and Masliah, 2010) . The relevance of these genetic models to study sporadic AD, where patients do not carry mutations in APP or PSEN, is debated.
Human embryonic stem cells (ESCs) and patient-derived induced pluripotent stem cells (iPSCs) allow modeling of human neurological disease in a human genetic context (Brennand et al., 2015; Paş ca et al., 2014; Vera and Studer, 2015; van den Ameele et al., 2014; Dolmetsch and Geschwind, 2011) . Neurons derived from iPSCs of FAD patients showed altered Ab 42 /Ab 40 ratio and abnormal Tau phosphorylation (Yagi et al., 2011; Israel et al., 2012; Shi et al., 2012; Kondo et al., 2013; Choi et al., 2014; Muratore et al., 2014; Hu et al., 2015) . Recently, a three-dimensional, human neural stem-cell-derived culture (Choi et al., 2014) displayed Ab plaque-like structures and Tau silver-positive aggregates (Choi et al., 2014) . The cells overexpress exogenous APP and PSEN FAD genes. No cell loss was detected, and neuroinflammatory and vascular components of the disease are lacking in this in vitro model. It remains, indeed, crucial to complement in vitro approaches with in vivo experiments to study human neurons in the context of the diseased brain.
Neural precursors derived from pluripotent stem cells (PSCs) (reviewed in Suzuki and Vanderhaeghen, 2015) can be transplanted into the rodent brain, resulting in specific patterns of cortical neuronal maturation, connectivity, and synaptic activity, well beyond what can be achieved in a purely in vitro condition (Gaspard et al., 2008; Espuny-Camacho et al., 2013; Michelsen et al., 2015) . We use here this approach to investigate whether Ab species generated in an AD mouse model (Radde et al., 2006) are sufficient to induce full AD pathology in non-affected, genetically non-manipulated human neurons. This chimeric model presents numerous Ab plaques and Ab-associated neuroinflammation in the human transplant and, importantly, the transplanted neurons show remarkable signs of neurodegeneration that are not detected in the mouse host brain or in transplanted PSC-derived mouse neurons. Thus, human neurons respond to Ab pathology differently than their murine counterparts in vivo.
RESULTS

Human-Grafted Neurons Integrate into the Mouse Brain and Are Exposed to Amyloid-b
We differentiated GFP-expressing human PSCs into cortical precursor cells in vitro to implant them as xenografts into the brains of newborn mice ( Figure 1A ; Figures S1E and S1F) (Espuny-Camacho et al., 2013) . We used transgenic Tg (Thy1-APPSw,Thy1-PSEN1*L166P) 21Jckr, further called APP/PS1-21, mice (Radde et al., 2006) and crossed them with immunodeficient NOD.CB17-Prkdc scid /J, further called NOD-SCID mice (Shultz et al., 1995) , to generate AD mice or wild-type (WT) littermates suitable for grafting experiments (Espuny-Camacho et al., 2013) . We additionally used GFP-expressing mouse neurons derived from murine PSCs as controls (Figures S2H and S2I) (Gaspard et al., 2008) .
The cells present a normal karyotype ( Figure S1D ) or comparative genomic hybridization (CGH) array (data not shown) and undergo neuronal and telencephalic/cortical specification in vitro as attested by beta III tubulin, Tau, Tbr1, and Ctip2 staining (Figures S1A-S1C). The transplanted human neurons express GFP and human-specific markers, like HuNuclei (Figures S1G and S1H), and present cortical (Tbr1 + , CTIP2 + , Satb2 + , and Brn2 + ), telencephalic (Foxg1 + ), and mature neuronal (NeuN + and MAP2 + ) identities Figures S1I and S1J) . Electron microscopy (EM), combined with GFP-immunogold labeling, shows numerous synapses between the human graft and the mouse host (Figures 1H and 1I) . RNA sequencing (RNA-seq) analysis confirms broad expression of telencephalic, cortical, and glutamatergic, and some expression of GABAergic, astrocytic, and oligodendroglia genes ( Figure S1K ). Cholinergic, dopaminergic, or neural crest-derived cell identities are less abundant or absent ( Figure S1K ). Ab plaques are present in the AD mouse host brain (GFP negative), as assessed by Thioflavin, 6E10, and Congo red staining (arrows; Figures 1L-1N ; Figures S2A-S2E ). Congo red + plaques
show birefringence when using plane-polarized light (Figure S2E) . Importantly, Ab plaques are detected within GFP + human neuronal clusters (arrowheads; Figures 1L-1M 0 ; Figures  S2A-S2B 0 , S2D, and S2E) and near single human neuronal cells integrated into the mouse host tissue (arrows; Figure 1N ; Figure S2C) . Ab plaques within human clusters are more diffuse than mouse host dense-cored plaques and are significantly smaller ( Figure 1O ; 120 ± 6 mm 2 in mouse host; 88 ± 8 mm 2 in human grafts). No significant differences in number of Ab plaques per unit surface are detected ( Figure 1P ; 40 ± 3 plaques/mm 2 in mouse host; 71 ± 16 plaques/mm 2 in human grafts). Ab reactivity is, as expected, not observed in WT mice (Figures 1J and 1K) . Ab plaque ultrastructure is very similar in the human transplants and in the mouse host: one or more cores of extracellular Ab filaments (asterisks) surrounded by dystrophic neurites (DNs) (arrowheads) (Figures 1Q-1T ). Immunogold labeling against human cell-specific markers, i.e., the GFP transgene or endogenous STEM121 marker, confirms that Ab deposits (asterisk) and dystrophic neurites are within grafted human clusters (arrowheads point to immunogold particles; Figures S2F and S2G). PSC-derived mouse neurons transplanted under similar conditions also present Ab plaques and DNs inside murine clusters ( Figures S2H-S2K) .
Thus, the transplanted neuronal clusters integrate into the mouse host tissue and are exposed to Ab deposits produced by the AD mice. 2N ), but neuroinflammation in mouse host and human transplants does not differ significantly. Microglia cells performing phagocytosis are detected (red arrowhead; Figure 2K ). Astrocytes and microglial cells within human clusters are mostly of host origin as attested by the lack of GFP immunoreactivity (arrowheads; . Ultrastructural analysis of astrocytes and microglia cells in human clusters in AD mice show an activated hypertrophic morphology with 76% and 74% of cells showing enlarged and/or phagocytic phenotypes, respectively . These phenotypes are rarely found in human grafts in WT mice (Figures 2O, 2Q, 2T, and 2V) , indicating that the elicited immune response is induced by the Ab-associated pathology and not a consequence of unexpected host-graft reactivity. Thus, both grafted human neuronal clusters and mouse host tissue are similarly exposed to Ab-associated neuroinflammatory responses characterized by astrocytic and microglial cell reactivity and recruitment to the Ab plaque sites. 
Amyloid-b-Associated Neuroinflammation in the Human
Extensive Neuritic Dystrophy and Alterations of Synaptic Markers Surrounding Ab Plaques in Human Neuronal Transplants
We examined the grafted human neuronal clusters exposed to Ab for signs of cellular or neuritic abnormalities. DN structures are found associated with Ab plaques in both mouse host and human grafts in AD mice 4 months post-transplantation (MPT) ( Figures 3A, 3B , 3D, and 3E), but not in WT mice ( Figures 3C  and 3F ). DNs present a globular structure ( Figures 3B and 3E ) and a heterogeneous content of vesicles (red boxes), dense bodies (red arrowheads), mitochondria (blue boxes), and neurofilaments (green boxes) ( Figures 3G-3N ). Myelin alterations are also detected (arrowheads; Figures S4K and S4L ). Ubiquitin staining confirms the presence of DNs around Thioflavin+ Ab plaques in mouse host tissue and human clusters 4 MPT ( Figures 3O-3R ) with 85% of Ab plaques surrounded by DNs in human grafts versus 58% in mouse host ( Figure 3S ). DNs are also detected in human clusters in AD mice by GFP or human-specific STEM121 staining (arrowheads; Figures 3O, 4C, and 4J; Figures S2L and S2M) but are absent in human grafts in WT mice (Figures 4A and 4H) . We observe abnormal accumulations of the presynaptic markers synaptophysin (SYP) and vesicular glutamate transporter 1 (VGlut1) around Ab plaques in human clusters in AD mice ( Figures 4C, 4D , 4J, and 4K), similar to the accumulations found in human AD brains (Brion et al., 1991) ( Figures S3A-S3D ). These accumulations are absent in human clusters in WT mice (Figures 4A, 4B, 4H, and 4I) and are less important in mouse host or in mouse neurons grafted in AD mice (Figures 4E, 4F, 4L, and 4M; , with 74% and 70% of Ab plaques in human grafts surrounded by SYP and VGlut1+ structures, respectively, versus 23% and 39% in mouse host ( Figures 4G and 4N ). The dendritic marker MAP2 reveals an area devoid of staining around Ab plaques in human clusters in AD mice (Figures 4O and 4P) that is minor in mouse host ( Figures 4Q and 4R ). The absence of MAP2 is mirrored by the accumulation of SYP + or Tau + structures around Ab plaques ( Figures S3I-S3P ). The postsynaptic marker Homer1 confirms the reduction of dendritic staining around Ab plaques in human neuronal clusters ( Figures S3Q-S3T ). Thus, DNs surrounding Ab plaques display abnormal accumulations of presynaptic and axonal proteins, while human dendritic and postsynaptic proteins become reduced. These neuritic changes are much more subtle in mouse host tissue or mouse neuronal clusters grafted in the AD mice.
Major Degeneration and Loss of Human Neurons In Vivo
Robust neuronal loss is a crucial AD hallmark lacking from existing animal models (Kokjohn and Roher, 2009; Morrissette et al., 2009; Crews and Masliah, 2010) . Remarkably, the density of human neurons at 6 MPT, evaluated using GFP together with the pan nuclear marker TOPRO3 ( Figures 5A-5F ) or HuNuclei (Figures S4A-S4F ), is much lower in transplants in AD mice ( Figures  5D-5F ) than in WT mice ( Figures 5A-5C ), although similar amounts of cells were injected. In contrast, nuclei density is similar in mouse host tissue in AD ( Figures 5J-5L ) versus WT mice ( Figures 5G-5I) .
Quantification shows that the density of mouse host tissue neurons is not significantly changed (98% in AD versus 100% in WT) while the density of human neurons in AD mice is reduced to 54% compared to WT animals ( Figure 5M ). The density of human neurons at 2 MPT-before Ab plaques are detected-is not different between AD and WT animals ( Figure 5M ). Thus, the human cells integrate normally and similarly in WT and AD mouse brain following transplantation and cell loss occurs specifically in AD animals at later stages when Ab pathology is present in vivo.
Semithin sections of human transplants stained with toluidine blue also show dense Ab plaques, disorganized neuropil texture, and reduced neuronal density in AD mice ( Figures 5N  and 5O ), while no such morphological alterations are seen in mouse host tissue and PSC-derived mouse grafts in AD mice. On the contrary, many healthy-appearing neurons are detected near Ab plaques (Figures 5P and 5Q; Figures S4I and S4J) . Ultrastructural analysis and quantification of neuron density confirm a significant decrease in the number of neurons in human grafts in AD at 6 MPT ( Figure 5W ; 1,463 ± 64 neurons/mm 2 in grafts in WT versus 344 ± 31 neurons/mm 2 in grafts in AD) and the absence of significant differences in mouse host tissue at this age ( Figure 5W ; 925 ± 47 neurons/mm 2 in host in WT versus 817 ± 37 neurons/mm 2 in host in AD).
Importantly, up to 33% of human neurons in AD mice show a necrotic phenotype ( Figure 5X ) characterized by electron lucent nuclei with highly dispersed chromatin, swelling of cytoplasm, and swelling and disintegration of cytoplasmic organelles 0 ) (Naga nska and Matyja, 2001; Ueda et al., 2007; Burattini and Falcieri, 2013) . Enlarged mitochondria with disrupted cristae (red arrowheads), large vacuoles (blue arrowheads), and even rupture of the nuclear membrane (green arrowheads) are also seen (Figures 5S 0 -5T 0 ). However, such phenotypes are completely absent in human neurons in WT mice (Figures 5R, 5R 0 , and 5X). The effects appear human specific as no signs of degeneration are observed in mouse host tissue or in PSCderived mouse neurons in AD mice (Figures 5V and 5X; Figure S4N) . Apoptotic cell death does not contribute strongly to the cell loss at this stage as no increased caspase-3-activated staining (data not shown) or TUNEL labeling is observed ( Figures  S4O-S4Z) .
Overall, the human grafts exposed to Ab undergo major neuronal loss and neurodegeneration in vivo via a necrosismediated mechanism. Moreover, this effect is species specific as mouse host neurons or grafted mouse neurons exposed to the same Ab load do not undergo degeneration.
Gradual Appearance of the 4R Tau Splicing Form in Human Neurons In Vivo
Adult murine brain mainly expresses the 4R Tau isoform containing four microtubule-binding repeats. During human brain embryonic development, only the 3R splice form of Tau is detected, while the adult human brain expresses 3R and 4R Tau splice forms in a 1:1 ratio (Goedert and Jakes, 1990) . We thus studied the expression pattern of Tau using specific antibodies raised against 3R or 4R Tau splice forms ( Figures  S5M and S5N ). After 2 and 4 MPT, 3R Tau is expressed, but 4R Tau is detected only in 0.7% of the human neurons (GFP + or STEM121 + ), while 4R Tau is widely expressed in mouse host tissue ( Figures 6A-6B 0 , 6E-6F 0 , and 6M; Figures S5A-S5C). However, at 6 MPT, 89% of the human neurons express high levels of 4R together with 3R Tau (arrows; Figures 6I-6J 0 and 6M; Figures S5G-S5I ). In addition, RNA-seq analysis of human grafts in old animals (8 MPT) shows a 3R/4R Tau expression close to 1, similar to the ratio in adult human brain ( Figure 6N ).
We wondered whether the appearance of 4R Tau could be accelerated in our model using two human iPSC lines derived from a patient carrying the pathogenic Tau mutation Ex10+16 (further indicated as Tau*) (Sposito et al., 2015) . This mutation is considered to favor 4R Tau expression and causes Frontotemporal dementia (FTD) (Hutton et al., 1998 (Sposito et al., 2015) . At 6 MPT, 84% of Tau* neurons highly expressed 4R together with 3R Tau Thus, major AD human-specific pathological hallmarks are reproduced with iPSC-derived human neurons from a FTD patient transplanted into AD mice.
Presence of Pathological Tau Species in Human Neurons In Vivo
We analyzed Tau pathology in the grafted human neurons. AT8 
Importantly, MC1
+ , which reveals a pathological Tau conformation, is also detected in few cell bodies of human neurons and human Tau* neurons (arrowheads; Figures 7K and 7N ; (Weaver et al., 2000) . However, no MC1 staining is found in mouse host tissue in AD mice (Figures 7Q, 7R, and 7T; 0 ), as previously described (Kokjohn and Roher, 2009; Morrissette et al., 2009) . The lack of MC1 reactivity in AD mouse host is probably not explained by human specificity of the antibody as it also labels mouse Tau in a pericyte-deficient APP transgenic mouse model (Sagare et al., 2013) . No AT8 or MC1 + staining is detected in WT mice ( Figures 7A, 7D , 7G, 7J, 7M, and 7P).
Cytoskeletal alterations with abnormal accumulation of straight 10-nm-wide neurofilaments are detected in DN of human neurons in AD mice 6-8 MPT ( Figures  S7V and S7V 0 ). In addition, Hirano bodies, paracrystalline inclusions with an array of symmetrically organized 8-10 nm filaments, are also present ( Figures S7W  and S7W 0 ). However, abnormal filaments in the form of paired helical filaments or twisted ribbons have not been detected.
These results show that even after 6-8 MPT the human neurons do not present definite tangle pathology although clear hyperphosphorylation and pathological conformational alterations of Tau are observed. Thus, there is major neurodegeneration even in the absence of full-spread tangle pathology in the human neurons. , 2000) . Genes involved in synaptic transmission, gated channel activity, and neuron projection (GO:007268, GO:0022836, and GO:0043005) are significantly downregulated at 8 MPT in human neurons in AD versus WT mice ( Figure 8A ; Figure S8 ; Table S5 ). Additionally, genes involved in cognition and learning and memory (GO:0050890 and GO:0007611) also show a trend toward downregulation. GO categories related to immune or inflammatory response (GO:0002376 and GO:0006954) show a non-significant upregulation. It should be noted that our analysis includes only the human gene expression programs in the transplanted neurons and not the murinederived immune cells of the brain ( Figure 8A ; Figure S8 ). Genes from the GO category regulation of cell death (GO:0010941) are upregulated at 8 MPT. Representative genes among these categories are shown in Figure 8B . Significant differential expression of mRNAs and non-coding RNAs is detected already at early, but more at late, stages in human transplants in AD versus WT mice (Tables S2-S5; for raw counts see Tables S6  and S7 ). Interestingly, among the most strongly upregulated genes in the human neurons in AD mice at 8 MPT (Table S4) are a couple of non-coding RNA genes: LINC01007 and RP11-89N17. 4 . Genes involved in myelination (MOBP, MAG, UGT8, MOG, and MBP) are also upregulated in the transplanted human cells. Alterations in myelination are known to occur in AD (Ettle et al., 2016; Bartzokis, 2011) , but few studies have investigated the role of oligodendrocytes and myelin in AD (De Strooper and Karran, 2016; Bartzokis, 2011) . In the list of downregulated genes, we find OTOF, GABRE, TAC1, PTK2B, and CACNA1H involved in neurotransmission and RHGAP36 involved in vesicle transport and regulation (Table S5 ). Interestingly COL25A1, also known as CLAC, is downregulated (Table S5) . CLAC specifically binds to fibrillized Ab and is present in Ab plaques in AD patients (Hashimoto et al., 2002; Tong et al., 2010) . To further evaluate the relevance of our model for human AD, we compared the gene expression data from human neurons with a published dataset of human AD samples . We performed co-expression clustering analysis using WCGNA (Langfelder and Horvath, 2008) , yielding modules of genes showing a similar expression pattern across samples (Figure 8C ). This analysis generated 37 modules from human transplants. The overlap of genes of these modules (left column) with the modules identified by Zhang et al. (2013) (right column) is determined using a Fisher's exact test. These data demonstrate that the transplanted human neurons show transcriptional changes in gene modules that are also affected in the human AD brain .
DISCUSSION
The generation of better in vivo models that closely resemble the pathological features present in the human AD brain is instrumental to test new hypotheses with regard to AD etiology and for the validation of new therapeutic approaches. Ideally, such a model would incorporate a human genetic background, be versatile and robust, and include aspects such as innate inflammation, cellular heterogeneity, and minimal use of transgenes to drive the pathogenesis (De Strooper and Karran, 2016) .
The main purpose of the current work was to ask to what extent a human/mouse brain chimera could be used to model critical aspects of AD previously uncovered by rodent models. We transplanted cortical neuronal precursors differentiated from one normal ESC line (H9) and from two FTD iPSC lines derived from the same patient into the brain of a well-characterized AD mouse model. Although three cell lines is a limited number, all displayed similar profound degeneration and necrosis when exposed to Ab in a large number of independent transplantation experiments. In addition, the human-specific pathology was compared with host mouse neurons and transplanted PSC-derived murine neurons, which show much more resistance to Ab pathology than the human neuronal counterparts.
At 4 MPT, already the human neurons show many signs of neurodegeneration. Dystrophic structures are found and presynaptic components, like synaptophysin and vesicular glutamate transporter 1, accumulate, while the dendritic marker MAP2 and the postsynaptic marker Homer1 disappear around Ab plaques.
At 6 MPT, a significant loss of human neurons is found to an extent that has never been reported for mouse neurons in the many existing models for AD. Neuronal density is strongly reduced (down to 54%) in human grafts in AD versus WT mice whereas no significant differences were observed in mouse host tissue. Importantly, at 2 MPT, similar densities of human neurons are observed in AD and WT mice, indicating that integration is normal, and cell loss occurs only later over the course of the disease. EM analysis revealed that 33% of human neurons in AD mice show signs of degeneration at 6 MPT. The cell loss appears to be mostly necrotic based on morphological criteria. Genome-wide expression analysis of human transplants (8 MPT) shows, however, upregulation of a broader category of genes related to regulation of cell death. This GO category contains many genes that are only indirectly involved in the regulation of cell death processes. Further work will be needed to clarify whether some of the altered genes play causal roles in the cell death process that we observed here.
Strikingly, this major neurodegeneration and human neuronal loss occur in the absence of detectable tangle pathology. It was recently suggested that the induction of neuronal tangles critically depends on the expression of 4R Tau as seen in the human adult brain (Choi et al., 2014) . At 2 and 4 MPT, the human neurons express mainly 3R isoforms, but after 6 MPT, 4R Tau isoforms are expressed in 89% of the human neurons. In addition, the 3R/4R Tau ratio in human neurons comes close to 1 at 8 MPT, as seen in the adult human brain, in contrast with most in vitro iPSC-derived models. We detect AT8 hyperphosphorylation and, notably, MC1 pathological conformational changes in Tau (Jicha et al., 1997) that are not detected in murine AD models. iPSCs expressing the Tau mutation Ex10+16 linked to FTD (Sposito et al., 2015) show an earlier appearance of 4R Tau and a higher tendency to cell death when exposed to Ab. The data are in line with the idea that Tau expression is crucial for Ab-induced toxicity in AD transgenic animals (Roberson et al., 2007; Leroy et al., 2012) . However, we did not detect Tau tangles after 8 MPT in human neurons or in human Tau* neurons. Likely, even longer periods in vivo are required for detectable tangle pathology, or additional seeding is needed to induce the tangle conformation. The NOD-SCID background needed for the experiments unfortunately does not allow analysis beyond 8 MPT due to increased incidence of graft-unrelated tumor formation.
Recently, a three-dimensional in vitro AD model with human neuronal stem cells that overexpress mutated FAD genes was reported (Choi et al., 2014) . This model uses matrigel as a 3D support matrix for the cells and recapitulates Ab pathology. The model also presents pathological Tau phosphorylation and Tau filaments but fails to show neurodegeneration or cell death. We have not modified our neurons with APP or PSEN mutations, and neurons were grown within the brain, which is arguably a more natural situation than the matrigel used in the cell culture system. It is intriguing that Tau aggregation was detected in the cell culture system without neurodegeneration. Further investigations are needed to better understand the relationship, if any, between abnormal Tau conformation and cell death.
A particularly important aspect of the current approach is that innate immunity, believed to play an important role in AD (Heneka et al., 2015) , remains apparently intact in the model. As shown, host-activated astrocytes and microglia cells are recruited to the human transplants, and similar neuroinflammatory responses are observed in human clusters and mouse host. Activated microglia cells have been proposed as essential for the cell loss in AD (Fuhrmann et al., 2010) , and this might explain the lack of cell loss in the 3D cell culture system discussed above. In further experiments, it should be relevant to study how the loss of function of microglia cells in the host affects neurodegeneration in the human neurons in vivo (Fuhrmann et al., 2010) . Lastly, our model allows a genome-wide transcriptome analysis of the human neurons exposed to Ab at early and late stages of the disease in vivo. Intriguingly, we observe two non-coding RNA sequences among the most upregulated genes. RP11-89N17.4 expression might be altered in AD patients (Gui et al., 2015) , and data from our lab show dysregulation of LINC01007 in AD patients (data not shown). While these findings are still premature, it should motivate additional work exploring the role of non-coding RNAs in neurodegeneration (Salta and De Strooper, 2012) . We also notice that COL25A1 is downregulated at late stages. Interestingly, rare variants in COL25A1 have been associated with healthy aging and possible protection against AD (Erikson et al., 2016) . Other upregulated genes are involved in cell death and myelination, while many downregulated genes are implied in memory and cognition, synaptic transmission, gated channel activity, neurotransmitter levels, and neuron projection. We validated our model comparing our results with the results of a previous genome-wide gene expression study of AD patient brains . The good concordance, taking into account that Zhang et al. (2013) provided data on total brain blocks from patients while we analyzed gene expression changes in human neurons specifically, is encouraging.
In conclusion, we present here a novel in vivo approach to investigate AD mechanisms in human neurons by generating a mouse/human brain chimera. This approach opens the door to explore how different human genetic backgrounds modulate AD-related features in vivo. The model is also of interest to further investigate whether and how Ab modulates Tau pathology and how this affects neurodegeneration. This initial work demonstrates clearly the importance of a human molecular and cellular background to observe full neurodegeneration in the presence of Ab plaques.
STAR+METHODS
Detailed methods are provided in the online version of this paper and include the following: Table S6 RNA-seq raw featurecounts from murine AD and WT cortex This paper Table S7 Experimental 
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Further information and requests for resources and reagents should be directed to and will be fulfilled by the Lead Contact Prof. Bart De Strooper (bart.destrooper@vib.be).
EXPERIMENTAL MODEL AND SUBJECT DETAILS Human and Mouse Pluripotent Stem Cells
Experiments were performed using the H9 line stably expressing GFP under the control of chicken b-actin promoter (H9-GFP line) generated previously (Espuny-Camacho et al., 2013), 2 iPSC lines carrying the Tau Ex10+16 mutation derived from one FTD patient (Sposito et al., 2015) and the mouse E14 line stably expressing GFP under the control of the chicken b-actin promoter (E14-GFP line) generated previously (Gaspard et al., 2008) . Human and mouse pluripotent stem cells (PSC) lines were cultured and passaged on mitotically inactivated mouse embryonic fibroblasts (MEFs) (Espuny-Camacho et al., 2013) .
Karyotyping and CGH Array
The karyotyping of the iPSC Tau Ex10+16 lines was analyzed by Cell Guidance Systems (UK). For the CGH array analysis of the ESC H9-GFP line, the genomic DNA was extracted using the QIAamp DNA Blood Mini QIAcube Kit on the Qiacube robotic workstation according to the manufacturer's instructions. Array analysis was performed using the 8x 60K CytoSure ISCA v2 microarray (AMADID 020040, Oxford Gene Technology, OGT, Oxford, UK). Genomic DNA was labeled for 2 hr using the CytoSure Labeling Kit (Oxford Gene Technology). The sample was labeled with Cy5 and hybridized versus Cy3-labeled sex-matched reference DNA. Hybridization was performed for minimum 16 hr in a rotator oven (SciGene, CA, USA) at 65 C. Washing of arrays was performed using Agilent wash solutions with a Little Dipper Microarray Processor (SciGene). Arrays were scanned using an Agilent microarray scanner at 2 mm resolution, followed by calculation of signal intensities using Feature Extraction software (Agilent Technologies). Visualization of results and data analysis was performed using the CytoSure Interpret Software (Oxford Gene Technology) and the circular binary segmentation algorithm. Quality control metrics are monitored with CytoSure Interpret software (Oxford Gene Technology).
AD and WT Immunodeficient Mice APP PS1 tg/wt mice (expressing KM670/671NL mutated APP and L166P mutated PS1 under the control of the Thy1.2 promoter1.1) (Radde et al., 2006) were crossed with the immunodeficient NOD-SCID mice (NOD.CB17-Prkdc scid ) that carry a single point mutation in the Prkdc gene (Shultz et al., 1995) . APP PS1 tg/wt Prkdc scid/+ mice from the F1 generation were crossed with NOD-SCID mice to generate APP PS1tg/wt Prkdc scid/scid immunodeficient mice. APP PS1 tg/wt Prkdc scid/scid mice were subsequently crossed with NOD-SCID mice to generate either APP PS1 tg/wt Prkdc scid/scid (AD mice) or APP PS1 wt/wt Prkdc scid/scid (WT mice) used for transplantations. Mice were housed in IVC cages in a SPF facility; light/dark cycle and temperature were always monitored. After weaning, no more than 4 animals of the same gender were kept per cage. The APP and PS1 genotyping was done as previously described (Radde et al., 2006) . The Prkdc genotyping was done by PCR amplification using the primers: Forward 5 0 GGA AAA GAA TTG GTA TCC AC 3 0 ; Reverse 5 0 AGT TAT AAC AGC TGG GTT GGC 3 0 ; followed by restriction digestion analysis of the amplicon with AluI enzyme (Roche Diagnostics). Products were analyzed on a 3% agarose gel. Transplantation experiments were performed in both male and female littermates at P0. The total number of animals used for transplantation and further analyses is indicated in Table S1 . Mouse work was performed in accordance with institutional and national guidelines and regulations, and following approval of the Ethical Committee of the KUL. All experiments conform to the relevant regulatory standards.
AD Human Brain Samples
Left hemisphere from 3 demented patients (patient 1: female, 60 years; patient 2: male, 65 years; patient 3: female, 70 years) clinically diagnosed as AD were taken at autopsy and fixed with formalin 10%. Tissue samples from several brain areas were further dissected and embedded in paraffin for microscopic examination. The neuropathological analysis confirmed the presence of numerous neurofibrillary tangles and senile plaques (Braak stage V-VI for neurofibrillary tangles, Thal stage 4 to 5 for Ab amyloid). Samples from the frontal cortex and from the anterior hippocampus (approximately 3x3x1 cm) were cut in 10 mm thick coronal sections and used for immunohistochemical analysis (Figures S3 and S7) . This study on post-mortem brain tissue was performed in compliance and following approval of the Ethical Committee of the Medical School of the Free University of Brussels.
METHOD DETAILS Pluripotent Stem Cell Differentiation into Cortical Cells
Human and mouse PSC cells were differentiated into cortical progenitors and neurons in vitro as previously described (Espuny-Camacho et al., 2013) . Briefly cells were dissociated manually or enzymatically using Stem-Pro Accutase on day-2, (Invitrogen A11105) and plated on matrigel (BD, hES qualified matrigel) coated-coverslips/dishes at low confluency (5,000-10,000 cells/cm2) in MEFconditioned hES/hiPS medium supplemented with ROCK inhibitor (Y-27632; 10 mM Calbiochem, 688000). On day 0 of the differentiation, the medium was changed to DDM supplemented with B27 (10 mL B27 per 500 mL DDM, GIBCO) and Noggin (100 ng/ml, R&D Systems) and the medium was replenished every 2 days. After 16 DIV, the medium was changed to DDM supplemented with B27 (GIBCO) and changed every 2 days. The cultures used for the experiments were routinely monitored for normal progenitor cell proliferation and rosette radial glia formation in culture under phase-contrast microscope analysis. Cultures that underwent normal parameters were used for transplantation experiments. At 14 DIV (for mouse PSC) and 24 DIV (for human PSC), the progenitors were manually or enzymatically (Stem-Pro Accutase) dissociated and injected into newborn mice recipients. Some cultures were kept in vitro after dissociation for cell identity analysis, resuspended in DDM supplemented with B27 and ROCK inhibitor (10 mM) and plated onto poly-Lysin/Laminin coated coverslips. 5-7 days after dissociation, half of the medium was replenished with Neurobasal supplemented with B27 (10 mL B27 per 500 mL DDM) and 2mM glutamine, and changed again every 5-7 days.
Intracerebral Grafting
Grafting experiments of human and mouse PSC-derived cortical progenitors and neurons were performed as previously described (Gaspard et al., 2008; Espuny-Camacho et al., 2013) using the APP PS1 tg/wt NOD-SCID (AD mice) and APP PS1 wt/wt NOD-SCID (WT mice) at P0. Briefly, human and mouse PSC-derived cortical progenitors and neurons were manually or enzymatically dissociated, supplemented with ROCK inhibitor (Y-27632; 10 mM Calbiochem, 688000) and injected into the frontal cortex of AD or WT mice. Around 100.000 cells were injected in suspension. The total number of animals used for transplantation and further analyses is indicated in Table S1 .
Immunofluorescence and Confocal Microscopy
For IF analysis, mice were anesthetized with CO2 and perfused with phosphate-buffered saline followed by 4% paraformaldehyde solution. The brain was then removed; post-fixed in the same fixative over 48-72 hr and cut into 60 mm slices on a Leica VT1000S vibratome. IF on grafted brains was performed as described previously (Arranz et al., 2010; Espuny-Camacho et al., 2013 ) using primary and secondary antibodies (see Key Resources Table) . Antigen retrieval was performed by microwave boiling the slides in 10 mM tri-Sodium Citrate buffer pH 6.0 (VWR). Nuclei staining was performed using a specific anti-human nuclei antibody (HuNuclei) (see Key Resources Table) , the pan-nuclear staining TOPRO3 (Invitrogen), or DAPI (SIGMA). Confocal Images were obtained using a Nikon Ti-E inverted microscope equipped with an A1R confocal unit driven by NIS (4.30) software. The confocal was outfitted with 20x (0.75 NA), 40x oil (1.4 NA) and 60x oil (1.4 NA) objectives lenses. For excitation 405 nm, 488 nm, 561 nm, 638 nm laser lines were used.
Immunohistochemistry
Mice were anesthetized with CO 2 , decapitated, and their brains were dissected and immersed in 10% (v/v) formalin for 24 hr. Brains were embedded in paraffin, cut on a Microm HM360 sliding microtome at 6 mm and mounted. Sections were deparaffinized in xylene, serially transferred to 100%, 90%, 70%, 50% ethanol solutions and rinsed. IHC was performed modifying the procedures described previously (Arranz et al., 2010; Espuny-Camacho et al., 2013) . Briefly, antigen retrieval was performed by boiling the slides at 120 C for 25 min in 10 mM Sodium Citrate buffer pH 6.0 (Sigma). After washing with Tris-buffered saline (TBS) buffer containing 0.1% (v/v) Tween-20 (TBST), permeabilization and blocking were performed by incubating the sections at 4 C for 12 hr with a blocking solution containing 10% normal horse serum, 1% BSA, 0.1% gelatin and 0.3 M glycine in TBST. Endogenous peroxidase activity was blocked by incubation with 0.3% hydrogen peroxide (Sigma) in TBS 30 min at RT. Then, the slides were washed and incubated with blocking solution containing 1% normal horse serum, 1% BSA, 0.1% gelatin and 0.3M glycine in TBST. After incubating with the primary antibody for 24 hr at 4 C, slides were washed and incubated with the biotinylated secondary antibodies 1 hr at RT. Primary and secondary antibodies used for IHC are described in the Key Resources Table. The slides were washed and incubated for 1 hr in the ABC solution (Vectastain Elite ABC kit, Vector Laboratories), and developed by using the ImmPACT TM DAB Peroxidase Substrate Kit (Vector Laboratories). Optionally the slides were stained with hematoxylin and Congo Red (see protocol below), dehydrated and mounted with DPX mounting medium (Sigma). Representative images were obtained using the Leica DM 2500M light microscope. AT8 and MC1 IHC were performed in serial sections with STEM121 IHC intended to determine the area of the human graft. AT8 and MC1 + signals were analyzed as mouse host tissue or human grafted cells depending on the location of STEM121 + signals.
Each dataset is mapped to the mixed database and depending on the origin, the corresponding human or mouse only database, using STAR RNA-seq aligner ) (same version, same parameters as used in this paper). For each mapping the number of reads mapping with a quality score > 10 to each database genome was determined. This yielded the following data:
Cross-Mapping One major concern when mapping a mix of human + mouse RNA to a RNA-seq database containing both human and mouse is that reads might accidentally map to the wrong genome. These results show that the percentage of cross mapping reads is very low. The (non-simulated) human and mouse material show a cross-mapping ratio of 0.5% and 0.1% (* 1 ). The simulated human and mouse material do not cross-map at all (* 2 ). The difference between the simulated and non-simulated data can be explained by (a) the non-simulated data has shorter read lengths (also shorter than the 100bp used in the paper) and (b) the fact that real biological data will contain genomic differences to the reference genome, adding to the potential to cross-map. It is therefore logical to assume that the cross-map percentage for the experiment in this paper will be better than the biological samples (A+B, due to the longer read length), but not as good as the artificial samples (C+D, due to the genomic variation).
Fraction of Reads Mapping
By selecting only reads that map with a quality score of 10 or better, we strongly select against reads which cannot be mapped to a unique location in the genome (using either the organism specific database or the mixed database) preventing cross-mapping. It is however possible that this drastically reduces the number of reads able to map, and hence reduces sensitivity of measuring of expression. We can assess this by checking how many reads map (of sample A+B) when mapped to the corresponding genome, and compare these numbers to the number of reads mapping to the mixed database. For sample A (human) we lose 2.3% of all reads (67.4%-65.1%). In the mouse sample we lose 12.2% (89.6%-77.4%). However, in both cases a very respectable amount of reads is still able to map uniquely to the genome. This data shows that it is possible to reliably map an RNA-seq dataset derived from mixed human and mouse sample.
QUANTIFICATION AND STATISTICAL ANALYSIS Morphological Analysis for Quantification
Morphometry and measurements were performed with Fiji/ImageJ software. For quantifications, at least 4-5 different brain sections comprising the human xenografts and the adjacent mouse host tissue were included per animal.
Immunofluorescence (IF) sections were imaged by confocal microscopy (Nikon Ti-E inverted microscope) with a 20x (0.75 NA) objective to image Z series stacks of areas inside human xenografts or mouse host tissue (8-10 optical sections 1 mm apart for each image). All images were acquired using identical acquisition parameters as 16-bit, 1024x1024 arrays. Z series stacks were then converted in Fiji/ImageJ to maximum intensity projections and threshold adjusted to isolate specific fluorescence.
Immunohistochemistry (IHC) sections were imaged using a Leica DM 2500M light microscope with a 63x objective. All images were acquired using identical acquisition parameters as 16-bit, 1024x1024 arrays.
Ultrathin EM sections comprising either the human xenografts or the adjacent mouse host tissue were imaged using a JEM-1400 transmission electron microscope (JEOL) equipped with a 11M-pixel Olympus SIS Quemesa camera. Images were taken in randomly selected areas at a 600x magnification.
Quantification of Ab Plaque Burden
The mean area of Ab plaques and the number of Ab plaques per area was manually determined on IF images using Fiji/ImageJ. Results are shown for mouse host (n = 5) and human grafts (n = 5) in AD mice 4MPT. Data are represented as mean ± SEM. Statistical analysis were done with Student's t test.
Statistical details of experiments can be found in Figure 1 and related figure legend. for mouse host from WT mice (n = 3 animals 4MPT; n = 4 6MPT); mouse host from AD mice (n = 3 animals 4MPT; n = 4 6MPT); human grafts from WT mice (n = 3 animals 4MPT; n = 4 6MPT); human grafts from AD mice (n = 3 animals 4MPT; n = 4 6MPT). Data are represented as mean ± SEM. Statistical analysis was done with two way-ANOVA with Bonferroni posttests. The percentage of hypertrophic and/or phagocytic astrocytes and microglia cells was calculated on EM images manually with Fiji/ ImageJ. Results are shown for human grafts in WT mice (n = 3) and human grafts in AD mice (n = 3) 6MPT. Data are represented as mean ± SEM. Statistical analysis were done with Student's t test.
Statistical details of experiments can be found in Figure 2 and related figure legend.
Quantifications of Ubiquitin+, SYP+, and VGlut1+ DNs
The percentage of Ab plaques surrounded by Ubiquitin + , SYP + and VGlut1 + DNs was manually determined on IF images using Fiji/ ImageJ. Ubiquitin results are shown for mouse host from AD mice (n = 5) and human grafts from AD mice (n = 5). SYP and VGlut results are shown for mouse host from AD mice (n = 5) and human grafts from AD mice (n = 5 and n = 4, respectively). Data are represented as mean ± SEM. Statistical analysis were done with Student's t test. Statistical details of experiments can be found in Figure 3 (for Ubiquitin), Figure 4 (for SYP and VGlut) and related figure legends.
Quantification of Cell Density
Ab plaques on IF images were visualized as masks (examples of Ab masks used for Figures 5E and 5K shown in Figures S4G and S4H ) and consequently a total area from the center of the plaque was drawn, akin to a Scholl analysis but with variable borders. The area was increased from the original detected mask of the plaques by a factor 50. Touching areas were fused and areas were calculated at each step. Nuclei were counted manually inside the areas and cell density was expressed as the number of nuclei per area. Data is represented as the % of relative cell density of AD versus WT mice. Quantification was performed at 2MPT or 6MPT: human grafts/AD mice (n = 4 mice 2MPT; n = 4 6MPT); human grafts/WT mice (n = 3 mice 2MPT; n = 4 6MPT); mouse host/AD mice (n = 4); mouse host/ WT mice (n = 4); human Tau* grafts/AD mice (n = 3 mice 6MPT); human Tau* grafts/WT mice (n = 3 mice 6MPT). Data are represented as mean ± SEM. Statistical analysis was done following one way-ANOVA with Bonferroni posttests. In addition, the neuronal density and the percentage of degenerating necrotic neurons were calculated manually on EM images using Fiji/ImageJ. Results are shown for mouse host in WT mice (n = 3), mouse host in AD mice (n = 3), human grafts in WT mice (n = 3) and human grafts in AD mice (n = 3). Data are expressed as mean ± SEM. Statistics were performed by two way-ANOVA with Bonferroni posttests.
Statistical details of experiments can be found in Figure 5 and related figure legend.
Quantification of the Percentage of 4R Tau+ Cells
The percentage of 4R Tau + /GFP + cells (in human grafts) or 4R Tau + /HuNCAM + cells (in human Tau* grafts) was manually determined on IF images using Fiji/ImageJ. Results are shown for human grafts 4MPT (n = 3) and 6MPT (n = 6 mice); human Tau* grafts 4MPT (n = 4) and 6MPT (n = 2 mice). Data are expressed as mean ± SEM. Statistical analysis was done following two way-ANOVA with Bonferroni posttests.
Statistical details of experiments can be found in Figure 6 and related figure legend.
Quantification of the Percentage of Ab Plaques Surrounded by AT8 or MC1 + DNs The proportion of Ab plaques surrounded by AT8 + or MC1 + DNs was determined manually on IHC images with Fiji/ImageJ. Results are shown for human grafts (n = 4 mice), human Tau* grafts (n = 3) and mouse host tissue (n = 3) in AD mice. Data are represented as mean ± SEM. Statistical analysis was done following one-way ANOVA with Kruskal-Wallis test.
Statistical details of experiments can be found in Figure 7 and related figure legend.
RNA-Seq Data Analysis
RNA samples of high quality and high RIN values (8-10) (RNA stability) were used for this study. 7 samples containing human grafted cells transplanted into AD animals and 7 samples of human grafted cells transplanted into WT animals were analyzed 4-5MPT. 5 samples containing human grafted cells transplanted into AD animals and 2 samples of human grafted cells transplanted into WT animals were analyzed 8MPT. The extracted RNA was analyzed by the VIB nucleomics core (http://www.nucleomics.be/) which generated polyA RNA-seq libraries using the Illumina Truseq stranded mRNA library prep protocol (Protocol 15031047 Rev E_October 2013). The libraries were sequenced on an Illumina Nextseq 500 sequencer, generating 100bp single-end reads. Raw reads were mapped to a combined database of the mouse (GRCm38/mm10) and human genome (hg19, gencode19) using the STAR RNA-seq aligner (version 2.4.2a) . Raw read counts were determined using the FeatureCounts software ) with a GTF file combining the human and mouse annotation with an alignment quality cutoff of 10.
